Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Bone and Mineral Research

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jbmr.5650090821PMID 7976512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.

  1994cited by this paper
• Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.

  1994cited by this paper
• Cytokines and estrogen in bone: anti-osteoporotic effects.

  1993cited by this paper
• Interleukin‐6: A Cytokine for Gerontolgists

  1993cited by this paper
• Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3.

  1993cited by this paper
• Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.

  1993cited by this paper
• Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction.

  1993cited by this paper
• Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and interleukin-1 levels in the circulation.

  1993cited by this paper
• 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

  1992cited by this paper
• Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity

  1992cited by this paper
• Incidence of clinically diagnosed vertebral fractures: A population‐based study in rochester, minnesota, 1985‐1989

  1992cited by this paper
• Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol.

  1992cited by this paper
• Spontaneous release of interleukin-I and interleukin-6 by peripheral blood mononuclear cells after oophorectomy.

  1992cited by this paper
• Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro

  1992cited by this paper
• Increased osteoclast development after estrogen loss: mediation by interleukin-6.

  1992cited by this paper
• Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

  1992cited by this paper
• Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone

  1991cited by this paper
• Avian osteoclasts as estrogen target cells.

  1991cited by this paper
• Evidence for interleukin‐1β production by cultured normal human osteoblast‐like cells

  1991cited by this paper
• Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone.

  1991cited by this paper
• Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

  1991cited by this paper
• Effect of age on variables relating to calcium and phosphorus metabolism in women

  1990cited by this paper
• Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.

  1989cited by this paper
• Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women.

  1989cited by this paper
• Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.

  1989cited by this paper
• Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.

  1988cited by this paper
• Evidence of estrogen receptors in normal human osteoblast-like cells.

  1988cited by this paper
• Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

  1988cited by this paper
• Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

  1988cited by this paper
• Involutional osteoporosis.

  1986cited by this paper
• HEPATITIS B NOT TRANSMISSIBLE VIA FÆCAL-ORAL ROUTE

  1975cited by this paper

• Regulatory effects of Dieckol on inflammatory cytokines and Osteoclastogenesis in Ovariectomized mouse model

  2025cites this paper
• Treatment of spinal lesions in breast cancer patients (literature review)

  2024cites this paper
• IL-6 Autoantibodies Predict Lower Platelet Counts and Altered Plasma Cytokine Profiles in Healthy Blood Donors: Results From the Danish Blood Donor Study

  2022cites this paper
• Menopause is associated with immune activation in women with HIV.

  2021cites this paper
• Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy

  2021cites this paper
• Interleukin-6 Could Be a Potential Prognostic Factor in Ambulatory Elderly Patients with Stable Heart Failure: Results from a Pilot Study

  2021cites this paper
• Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

  2021cites this paper
• The Role of Bone Turnover Markers in the Follow up of the Treatment of Osteoporosis

  2020cites this paper
• Estrogens and progestins

  2020cites this paper
• Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans

  2020cites this paper
• Systemic Inflammation: A Risk Factor for Osteoporosis in Pre- and Post-menopausal Women

  2020cites this paper
• Biology and Clinical Aspects of Estrogen Action on Bone

  2019cites this paper
• Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview

  2019cites this paper
• Biomarkers of Aging.

  2018cites this paper
• Aging and Aging-Related Diseases: Mechanisms and Interventions

  2018cites this paper
• The Role of Inflammation in Age-Related Sarcopenia

  2017influential citation
• Menopause Transition and Postmenopausal Period: Relationship with Inflammatory Markers, Physical Activity Energy Expenditure and Bone Mineral Density in Healthy Women

  2017cites this paper
• Exercise Improves Insulin Sensitivity in the Absence of Changes in Cytokines.

  2016cites this paper
• Skin: Acne vulgaris genetics and molecular responses to bacterial challenges

  2016cites this paper
• СИСТЕМНАЯ СКЛЕРОДЕРМИЯ И ОСТЕОПОРОЗ

  2016cites this paper
• Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women

  2016cites this paper
• Satellite cells in human skeletal muscle plasticity

  2015cites this paper
• Low grade inflammation is associated with lower velocity of sound and broadband ultrasound attenuation in older men, but not with bone loss or fracture risk in a longitudinal aging study.

  2015cites this paper
• Dietary Factors and Chronic Low-Grade Systemic Inflammation in Relation to Bone Health

  2015cites this paper
• Evaluation of insulin like growth factor-1 (IGF-1) level and its impact on muscle and bone mineral density in frail elderly male.

  2015cites this paper
• Circulating cells as biomarkers in cardiovascular disease : the difference between men and women

  2015cites this paper
• Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α

  2014cites this paper
• Evaluation and management of anemia in the elderly

  2014cites this paper
• Association Between Inflammatory Biomarkers and Bone Mineral Density in a Community‐Based Cohort of Men and Women

  2014cites this paper
• [Osteoporosis - inflammatory effects on bone metabolism and fracture risk].

  2014cites this paper
• Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE).

  2014cites this paper
• Osteoporose – inflammatorische Effekte auf den Knochenstoffwechsel und das Frakturrisiko

  2014cites this paper
• Inverse relationship between neutrophil lymphocyte ratio (NLR) and bone mineral density (BMD) in elderly people.

  2013cites this paper
• Nutrition, Aging, and Chronic Low-Grade Systemic Inflammation in Relation to Osteoporosis and Sarcopenia

  2013cites this paper
• Regulation of the gp 80 and gp 130 Subunits of the IL-6 Receptor by Sex Steroids in the Murine Bone Marrow

  2013cites this paper
• IL-1β level in Sudanese patients with atherosclerotic coronary heart disease

  2012cites this paper
• FIT OR FAT: THE RELATIONSHIP OF INFLAMMATION, INTRAMUSCULAR FAT AND MUSCLE, AND MOBILITY FUNCTION IN OLDER ADULTS by Odessa

  2012cites this paper
• Inflammation, Aging, and Adiposity: Implications for Physical Therapists

  2012cites this paper
• Adiposidad, estado pro-inflamatorio y resistencia a la insulina durante la menopausia.

  2012cites this paper
• Serum Levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and Their Association with Markers of Bone Metabolism in Vitamin D-Deficient Female Students

  2012cites this paper
• A Comprehensive Review of the Shared Roles of Inflammatory Cytokines in Osteoporosis and Cardiovascular Diseases as Two Common Old People Problem; Actions Toward Development of New Drugs

  2011cites this paper
• Vitamin D and Bone Health; Potential Mechanisms

  2010cites this paper
• Proinflammatory cytokines and osteoporosis

  2009cites this paper
• Pathophysiology of osteoporosis

  2009cites this paper
• Associations of interleukin-6 with interleukin-1beta, interleukin-8 and macrophage inflammatory protein-1beta in midlife women.

  2008cites this paper
• Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

  2008cites this paper
• Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.

  2008cites this paper
• NUTRITION ET OSTÉOPOROSE

  2008cites this paper
• Local Regulators of Bone: IL-1, TNF, Lymphotoxin, Interferon-γ, the LIF/IL-6 Family, and Additional Cytokines

  2008cites this paper
• Correlations of Serum IL-6 Levels and Prolidase Activity Between Bone Turnover Markers and Bone Mineral Density in Postmenopausal Women With and Without Osteoporosis

  2007cites this paper
• Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers.

  2006cites this paper
• Interleukin-6 in aging and chronic disease: a magnificent pathway.

  2006cites this paper
• CHAPTER 7 – Prostaglandins and Proinflammatory Cytokines

  2006cites this paper
• CHAPTER 37 – Laboratory Assessment of Postmenopausal Osteoporosis

  2006cites this paper
• Laboratory Assessment of Postmenopausal Osteoporosis

  2006cites this paper
• Prostaglandins and Proinflammatory Cytokines

  2006cites this paper
• RESISTANCE TRAINING AND MEASURES OF INFLAMMATION IN RELATION TO BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN

  2005cites this paper
• Biological variations, genetic polymorphisms and familial resemblance of TNF-α and IL-6 concentrations: STANISLAS cohort

  2005cites this paper
• Sex hormones and the immune response in humans.

  2005cites this paper
• Evaluation of interleukin-1 and -6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children.

  2005cites this paper
• Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation.

  2005cites this paper
• The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis

  2004cites this paper
• Postmenopausal testosterone therapy and breast cancer risk.

  2004cites this paper
• A new austenitic stainless steel with a negligible amount of nickel: an in vitro study in view of its clinical application in osteoporotic bone.

  2004cites this paper
• Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation

  2004cites this paper
• Bone Mineral Density of the Lumbar Spine is Associated with TNF Gene Polymorphisms in Early Postmenopausal Japanese Women

  2004cites this paper
• Osteoporosis and biomaterial osteointegration.

  2004cites this paper
• Biological Interactions of Aging and Anemia: A Focus on Cytokines

  2003cites this paper
• Biomimetic PMMA-based bone substitutes: a comparative in vitro evaluation of the effects of pulsed electromagnetic field exposure.

  2003cites this paper
• Chapter 73 – Pathophysiology of Osteoporosis

  2002cites this paper
• Local Regulators of Bone: IL-1, TNF, Lymphotoxin, Interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 Family, and Additional Cytokines

  2002cites this paper
• Interleukin‐1α (IL‐1α) promotes angiogenesis in vivo via VEGFR‐2 pathway by inducing inflammatory cell VEGF synthesis and secretion

  2002cites this paper
• Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women.

  2002cites this paper
• Regulation of estrogen synthesis in postmenopausal women.

  2002cites this paper
• Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome.

  2002cites this paper
• Expression of Interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women.

  2002cites this paper
• L-arginine and L-lysine stimulation on cultured human osteoblasts.

  2002cites this paper
• Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women.

  2002cites this paper
• Changes in proinflammatory cytokine activity after menopause.

  2002cites this paper
• Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population.

  2002cites this paper
• Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women.

  2002cites this paper
• Response of biochemical markers of bone turnover to estrogen treatment in post-menopausal women: Evidence against an early anabolic effect on bone formation

  2001cites this paper
• Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes.

  2001cites this paper
• Interleukin 6 and Haemostasis

  2001cites this paper
• Can manipulation of the ratios of essential fatty acids slow the rapid rate of postmenopausal bone loss?

  2001cites this paper
• Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

  2001cites this paper
• Cytokines and Bone Loss in a 5‐Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin‐6 Receptor and Increases Interleukin‐1‐Receptor Antagonist: The Danish Osteoporosis Prevention Study

  2000cites this paper
• Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle.

  2000cites this paper
• Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus.

  2000cites this paper
• Determination of total interleukin-8 in whole blood after cell lysis.

  2000cites this paper
• gp130 Cytokine family and bone cells.

  2000cites this paper
• Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women.

  2000cites this paper
• Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging.

  2000cites this paper
• CYTOKINES IN THE PATHOGENESIS OFPOSTMENOPAUSAL OSTEOPOROSIS AND RELATIONSHIP BETWEEN CYTOKINES AND OSTEOCALCIN

  2000cites this paper
• Measurement of Cytokines in Clinical Samples Using Immunoassays: Problems and Pitfalls

  2000cites this paper
• The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17beta-estradiol and prolactin.

  1999cites this paper
• Oestrogens prevent the increase of human serum soluble interleukin‐6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro

  1999cites this paper
• Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.

  1999cites this paper
• The Expression of Interleukin-6 (IL-6), IL-6 Receptor, and gp130-Kilodalton Glycoprotein in the Rat Decidua and a Decidual Cell Line: Regulation by 17β-Estradiol and Prolactin1.

  1999cites this paper
• Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism.

  1999cites this paper